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Abstract: BACKGROUND: The objective of this study was to estimate the prevalence of depression and anxiety disor-
ders in hospitalized patients at the dermatology ward at a university hospital in São Paulo, Brazil. 
OBJECTIVE: To assess the prevalence of mood and anxiety disorders in hospitalized patients at the dermatology
ward at a university hospital in São Paulo. 
METHOD: A total of 75 patients, men and women, aged between 18 and 76 years, took part in the research. The
study employed a descriptive, cross sectional and correlational method. The data was collected by means of a
social demographic questionnaire and the PRIME-MD. 
RESULTS: It was found that 45.3 percent of the subjects presented with depressive symptoms, and 52 percent pre-
sented with symptoms of anxiety and that this survey showed moderate and high significant correlations
(p<0,01; r= 0,616) for depression and anxiety. 
CONCLUSION: These facts could evidence the relationship between physical and psyche, just as the literature 
presents.
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Resumo: FUNDAMENTOS: O presente estudo teve como objetivo verificar a freqüência de depressão e ansiedade em
pacientes internados na Divisão da Clínica de Dermatologia de um hospital universitário de São Paulo. 
OBJETIVO: Avaliar a prevalência de depressão e ansiedade em pacientes hospitalizados na enfermaria da clínica de der-
matologia de um hospital universitário em São Paulo. 
MÉTODO: Participaram da pesquisa 75 sujeitos, homens e mulheres, entre 18 e 76 anos. O delineamento do estudo
foi transversal e descritivo. Os instrumentos utilizados foram Entrevista Sócio Demográfica e PRIME-MD. 
RESULTADOS: Identificou-se a presença de depressão em 45,3% e de ansiedade em 52% dos pacientes avaliados. 
CONCLUSÃO: Verificou-se correlação moderada e altamente significativa (p<0,01; r =0,616) para os índices de depres-
são e ansiedade, que pode evidenciar a relação entre adoecimento físico e psíquico muito encontrada na literatura.
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INTRODUCTION
The frequency of major mental disorders (such
as depression and anxiety) that come to general med-
ical attention has been the subject of much health
research. The reason for the growing scientific interest
is due to the high prevalence of mental disorders in
the population, estimated to be between 12.2 and
48.6 percent, and 20 to 60 percent in hospitalized
patients in general hospitals and 30 percent among
dermatologic patients.1,2
Unfortunately, most of these patients do not
have their diagnosis recognized and are not treated.1
The estimate is that 55 percent of the patients seen
with major depression are not diagnosed; although
this estimate rises to 77 percent when generalized
anxiety disorders are considered. Some of the princi-
pal reasons for the non-recognition of mental disor-
ders are the high probability of these patients report-
ing only somatic symptoms during the consultation
and the doctors´ difficulty in recognizing these symp-
toms as evidence of mental disorders.1
A study carried out in 151 patients in a public
health outpatients service of a dermatology clinic in the
South of the country has found that the frequency of anx-
iety was 40.39 percent and the frequency of depression
was 43.7 percent.3 Most of the patients were women
(67.5 percent) with low levels of education (68.2 percent
having at least completed elementary school), and an
average of 55.06 years of age (DP=14.75).
The prejudices that occur when these disorders
are not treated are innumerable and affect many areas
of life such as: psychic and somatic suffering, discrim-
ination, social isolation, interruption of studies and
work, drug and alcohol abuse, suicide, homicide, self
and hetero-aggression, low academic and occupation-
al performance and an increase in mortality. Many
studies have shown that these disorders have an
important negative impact on the quality of life, even
greater than chronic non-psychiatric medical condi-
tions. In the case of dermatologic illnesses, depres-
sion is often related to the beginning or the aggrava-
tion of skin lesions.2
Nowadays there has been an increase in the
number of studies which involve the integration
between medical and psychological aspects.
Psychodermatology is a branch which involves the
study and treatment of dermatologic problems which
are caused and/or influenced by psychological factors.4,5
Many authors write about the relationship between
skin and mental conditions due to its importance on
the ego construction, presenting the skin as a limiting
organ that communicates with the external world.4-9
Due to this limiting function, skin disease can
cause individual embarrassment. Some authors sug-
gest that, due to the visibility of the lesions, it is diffi-
cult for patients not to feel embarrassed, anxious or
depressed.8-13 Many patients report self-derogatory
feelings because, in popular beliefs, dermatologic dis-
eases can be associated with dirt, ugliness and conta-
giousness, causing social fear, isolation and embar-
rassment.11 Thus, there is an implication between skin
diseases and emotional aspects.14,15
Therefore, the objective of this study was to
estimate the prevalence of mood and anxiety disor-
ders in hospitalized patients in the dermatology ward
at a university hospital in São Paulo.
MATERIAL AND METHODS
A cross sectional study carried out on a repre-
sentative sample of 75 hospitalized patients in a der-
matology division ward at a university hospital in São
Paulo, from April to October 2010. The number of
patients was calculated based on the quantity of
admissions on this ward on the first semester of 2008
(241 admissions), using the conservative estimation of
prevalence of psychiatric disorders on internee
patients (30%), with a confidence interval of 95%. The
following were considered exclusive factors: younger
than 18 years (legal age) and having any disease that
could interfere with cognition. Three instruments
were applied within 72 hours of hospitalization: the
Mini Mental State Examination, the Social
Demographic Questionnaire, and the PRIME-MD.
The Mini Mental State Examination (MEN) is an
instrument widely used to trace cognitive compro-
mise.16 The exam is much used in clinics and research
for detecting cognitive losses, disease follow-up and
monitoring treatment response. The instrument is
composed of the following items: questions that
assess temporal orientation, spatial orientation, short-
term memory, calculation and attention. This instru-
ment was used to screen and determine whether or
not to include patients in the study.
The social demographic questionnaire is com-
posed of 14 questions on demographic data (such as
sex, age, civil state, and profession), three clinical
questions: diagnosis, duration of treatment and num-
ber of hospitalizations, and one open question about
life changes after the disease appeared.
The PRIME-MD is an instrument that facilitates
the accurate and rapid recognition and diagnosis of
mental disorders; it is the most frequently employed
instrument for adults and primary attention services.17
PRIME-MD utilizes standard questions that directly
focus key diagnostic symptoms and also a decision-
tree model that facilitates the differential diagnosis. In
this study, the Mood Module and Anxiety Module of
the instrument were used to achieve the objectives.
The results of the social-demographic, clinical
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and PRIME-MD variables were submitted to an
exploratory analysis, obtaining Frequency, Average,
Standard Deviation and parametric test (Pearson’s r),
correlating the social-demographic and clinical vari-
ables to depression and anxiety results by means of
the SPSS 13.0 program, with p<0.05 considered sig-
nificant association. The project was approved by the
Ethics Committee of the Institution.
RESULTS
The sample was composed of 75 patients, most
of them female (47 - 62.6 percent). The average age
was 44.5 years, varying from 18-76 years (Standard
Deviation (SD) = 16 years). The main social-demo-
graphic characteristics are depicted on table 1.
The most prevalent dermatologic diseases were:
psoriasis (18.6 percent), skin lesions under clinical
investigation (14.6 percent), lupus (9.3%), eczema (8
percent), pemphigus vulgaris (6.6 percent), Leprosy
(5.3 percent) and epidermolysis bullosa, vasculitis and
scleroderma with 4 percent each. The average time for
dermatologic disease evolution was 68 months, with
an average of two hospitalizations.
Most of the patients (21.3 percent) reported
the onset of symptoms 10 years ago and were on their
first hospitalization (58.7 percent). The table with
clinical data is attached below (Table 2).
The frequency of depression was 45.3 percent
and of anxiety was 52 percent.
There were no correlations between mood and
anxiety disorders and the variables (sex, age, civil
state, family income, schooling, time of evolution of
disease and number of hospitalizations).
The table with prevalence of mood and anxiety
disorder data is attached below (Table 3).
TABLE 1: Distribution of patients according to social
demographic data. Results Social Demografic
Characteristics N %
Gender
Male 28 37,3
Female 47 62,6
Age
18 – 29 years 17 22,6
30 – 39 years 10 13,3
40-49 years 20 26,6
50-59 years 11 14,6
60 – 69 years 12 16
70- 76 years 5 6,6
Schooling
0 – 4 years 23 30,6
5-8 years 15 20
9-11 years 24 32
More than 11 years 13 17,3
Marital State
Single 25 33,3
Married 25 33,3
Widow 8 10,6
Living Togheter 12 16
Divorced 5 6,7
Color
Asian 1 1,3
White 49 65,3
Brown 18 24
Black 7 9,4
Family Income
Less than 1MW* 6 8
1 – 5 MW 59 78,6
6 – 10 MW 8 10,6
More than 10 MW 2 2,6
Occupation
Employed 39 52
Unemployed 13 17,3
Housewife 10 1,3
Retired 13 17,3
TABLE 2: Distribution of patients according to clinical
characteristics
Variable N %
Time of Disease
Less than a month 14 18,7
1 a 6 months 12 16
1 a 3 years 5 6,7
3 a 5 years 18 24
5 a 10 years 10 13,4
More than 10 years 16 21,3
Hospitalizations
1ª 44 58,7
2ª 13 17,3
3ª 5 6,7
4ª 7 9,3
5ª 2 2,7
6ª 1 2,7
10ª 1 2,7
15ª 1 2,7
TABLE 3: Prevalence of Depression and Anxiety
*MS:  Minimum Wage (R$510,00)
Disorder N %
Depression
Yes 34 45,3
No 41 54,6
Anxiety
Yes 39 52
No 36 48
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A statistical correlation between depression and
anxiety (p<0.01, r=0.616) was found, so the patient
who presented a depressive mood tended to present
signs and symptoms of anxiety as well.
The main depressive symptoms in patients
diagnosed with depression were: depressed mood,
fatigue, loss of energy, insomnia or hypersomnia, guilt
and uselessness. 
The table with the distribution of depressive symp-
tomatology in the patients is shown below (Table 4).
Jitters, anxiety or inquietude, insomnia, wake-
fulness after little sleep, irritability and boredom were
the principal symptoms reported by patients with an
anxiety diagnosis. The table with the distribution of
anxiety symptomatology in the patients is attached
below (Table 5).
Concerning the changes that occurred after the
appearance of the skin disease, most of the patients
reported a negative body and self-image perception.
Patients reported feelings of inadequacy, sadness and
low self-esteem. The curiosity and annoyance brought
on by other people’s fear of contagion caused feelings
of shame and discomfort, leading the person to social
isolation and prejudice in professional and social
areas. The changes that occurred after the appearance
of skin disease are attached below (Chart 1).
DISCUSSION
This study has found that the frequency of
anxiety was greater than the frequency of
depression in hospitalized patients in the
Dermatology Clinic Ward studied. This outcome
was different from a study with dermatologic
patients on the South of the country.3 The gen-
eral results found corroborated those of the lit-
erature in which the prevalence of theses disor-
ders in a general hospital ward are 20 percent to
60 percent.1
The prevalence of anxiety and depression were
neither correlated to social-demographic questions
(sex, age, familiar income, occupation) nor to clinical
conditions (time of evolution of the disease and num-
ber of internments). They were correlated to negative
impact caused by the skin disease on functionality and
quality of life, since it is exposed and visible, influenc-
ing self-perception and social relations.
We were able to observe in our literature review
that the visibility of skin lesions causes embarrass-
ment, sadness, shame and anxiety.6,10,11,15 This study
was able to prove this fact by the number of reports
about changes in lives after the onset of skin disease,
concomitant to the presence of mood and anxiety dis-
orders.² The frequency of depression in patients with
skin diseases in the literature (30 percent) was 10 per-
cent smaller than the one found in this study.
These patients also reported stigma and bias
because of their skin diseases. On common thought,
skin disease is related with dirt, ugliness and conta-
giousness, which surely can be the cause of avoidance
by others. After the onset of the skin disease, a nega-
tive perception of the body image was found in these
patients.15 These data corroborate that of another
study that reported self-derogatory feelings in patients
with skin diseases, along with social isolation, fear and
shame.2,14,15
TABLE 4: Distribution of depressive symptoms, according to the presence or absence of a diagnosis 
of depression
Depressive Patients with Patients without 
Symptomatology depression depression 
diagnosis (N=34) diagnosis (N=41)
Imnsomia or Hypersomnia 29 (85,2%) 18 (43,9%)
Fatigue or loss of energy 30 (88,2%) 16 (39,0%)
Decrease or Increase in appetite 21 (61,7%) 14 (34,1%)
Less interest on daily life activities 26 (76,4%) 6 (14,6%)
Depressed humor 32 (94,1%) 4 (9,7%)
Feelings of inutility or guilt 29 (85,2%) 7 (17,0%)
Decrease of concentration 19 (55,8%) 7 (17,0%)
Psychomotor Agitation or Retardation 30 (88,2%) 11 (26,8%)
Frequent death thoughts 19 (55,8%) 3 (7,3%)
CHART 1: Self-reported changes after skin diseases
Humor alteration 31
Stigma/Bias 23
Alteration of self-image 20
perception
Alteration of routine of daily 20
activities of life and  leisure
Prejudice at work 18
Presence of pain 8
No changes reported 5
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CONCLUSION
According to the data found in this study it was
possible to observe that the frequency of mood and anx-
iety disorders in hospitalized patients at the dermatol-
ogy ward was 52 percent for anxiety and 45.3 percent
for depression. These frequencies were not correlated
to clinical or social-demographic variables; however
they were correlated to negative impact on functionality
and quality of life caused by the skin disease. This fact
emphasizes the importance of multidisciplinary teams
in the attention to patients in general hospitals due to
the high co-morbidity with psychiatric disorders. 
Finally, it is important to highlight that the
experiment planning of this study was cross sectional
and exploratory, which enabled us to verify the preva-
lence of mood and anxiety disorders in dermatologic
patients at a specific moment only. Studies that verify
if early detection and monitoring of these symptoms
can improve the quality of life and prognosis of these
patients are quite necessary. ❑
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Anxiety Symptomatology Patients with anxiety Patients without anxiety 
diagnosis(N=39) diagnosis (N=36)
Jitters, Anxiety or Inquietude 38 (97,4%) 10 (27,7%)
Psychomotor Agitation 28 (71,7%) 1 (2,7%)
Loss of energy 33 (84,6%) 3 (8,3%)
Presence of muscle tension 32 (82,0%) 2 (5,5%)
Difficulty to fall asleep or to keep sleeping 35 (89.7%) 2 (5,5%)
Decrease of concentration 23 (58,9%) 1 (2,7%)
Irritability and Discomfort 35 (89,7%) 7 (19,4%)
TABLE 5: Distribution of anxiety symptoms, according to presence or absence of a diagnosis of Anxiety
